Through the Mother & Baby Substance Exposure Initiative (MBSEI), Health Management Associates (HMA) provided consultative services, coaching and other technical assistance (TA), on behalf of the California Department of Health Care Services (DHCS), to increase access to MAT using the three FDA-approved medications for the treatment of opioid use disorder (OUD). The goal of the initiative was to reduce unmet treatment needs and reduce opioid overdose related deaths through the provision of prevention, treatment and recovery activities for OUD. Additionally, the initiative aimed to decrease neonatal abstinence syndrome (NAS) severity and length of stay in the hospital, and to increase the number of mothers in long-term recovery.
The grant period was January 2019 to December 2020. During this time, HMA worked hand-in-hand with the California Maternal Quality Care Collaborative (CMQCC) and the California Perinatal Quality Care Collaborative (CPQCC) to deliver state-of-the-art treatment from the prenatal phase to the post-delivery phase. The outcomes include:
Throughout the website, the terms mother or maternal or she or her are used in reference to the birthing person. We recognize not all birthing people identify as mothers or women. We believe all birthing people are equally deserving of patient-centered care that helps them attain their full potential and live authentic, healthy lives.
The Mother & Baby Substance Exposure Initiative will reach up to 12 counties.
Health Management Associates (HMA) recorded and collated a series of videos that provide a brief overview of content related to perinatal substance use disorder and highlight the expertise of our subject matter experts (SMEs). HMA SMEs have direct experience leading and collaborating with organizations serving pregnant and parenting mothers with OUD, and their affected babies and families. These short videos, ranging in duration from 10-20 minutes, aim to briefly introduce the SMEs, expose you to a few of our areas of expertise, and provide useful content for your work with this population.
With the dissemination of patient and community level information, pregnant and/or parenting mothers can feel more comfortable within the healthcare system and see it as a refuge rather than an adversary. Along with this, we have implemented standardized approaches to pregnant and/or parenting women in the prehospital, hospital, and post-delivery phase in each of the participating counties.
For more information about Mother & Baby Substance Exposure Initiative, please contact Charles Robbins at crobbins@healthmanagement.com
Please check back later to view our upcoming events.
Featured Resources
Webinar/Podcast/Video
open link in new page
For the past two years, the Mother and Baby Substance Exposure Initiative (MBSEI) has grounded itself in four principles of perinatal substance use: • Every pregnant woman should be screened • Every pregnant woman with OUD should be on MAT • Use non-pharmacologic treatment for NAS • Moms and Babies should receive support to keep them together Watch these principles come to life in a fifteen-minute video portraying the stories of moms and babies and the providers supporting them in navigating the perinatal substance use treatment system.
ViewUse the below filters to narrow your search
Setting
Topic
File Type
November 20, 2020 - Webinar/Podcast/Video
open link in new page
For the past two years, the Mother and Baby Substance Exposure Initiative (MBSEI) has grounded itself in four principles of perinatal substance use: Every pregnant woman should be screene, Every pregnant woman with opioid use disorder should be on medication-assisted treatment, Use non-pharmacologic treatment for neonatal abstinence syndrome, and Moms and babies should receive support to remain together. We invite you to watch the final webinar in the MBSEI series as these four principles come to life in a 15-minute video portraying the stories of moms, babies and providers as they navigate the perinatal substance use treatment system. Following the video, experts working in the field participated in a moderated discussion and Q&A session.
October 26, 2020 - Webinar/Podcast/Video
open link in new page
Please watch this informative, engaging, and practical discussion on addressing social determinants of health among women and babies exposed to opioid use disorder (OUD) and substance use disorder (SUD). HMA experts focus on housing insecurity and domestic violence among the various social determinants of health affecting the overall quality of life. health risks and outcomes impacting pregnant women and mothers with OUD/SUD. Speakers also address social and community resources and structures supporting health and wellbeing in the places where this population lives, learns, works and plays.
November 13, 2020 - Webinar/Podcast/Video
open link in new page
Pregnant and parenting women with substance use challenges face many social barriers including misperceptions, judgment and stigma. These experiences can also occur in the process of their seeking healthcare. It is the aim of these presentations to provide clinicians and teams with enhanced awareness, knowledge and skills toward the elimination of health inequities and improved patient experience of care.
May 21, 2020 - Webinar/Podcast/Video
open link in new page
In this webinar, Dr. Shannon Robinson will discuss current concepts regarding toxicological testing. These include ensuring you are able to detect the substances you are looking for and ways to address inconsistent results without increasing patient resistance.
September 22, 2020 - Webinar/Podcast/Video
open link in new page
In partnership with the OC Social Services Agency, Health Management Associates invites you to register and join us for a two-part webinar on Enhancing Child Welfare Support for Families affected by Substance Use Disorder/Opioid Use Disorder. THE SESSIONS WILL COVER: Family connection and resilience, Collaborative case planning, Safety organized practice and core practice model, Community child protection ecosystem, Collaborative case planning. THIS TRAINING IS APPROPRIATE FOR SUPERVISORS, MANAGERS, AND COURT OFFICIALS.
March 13, 2020 - Webinar/Podcast/Video
open link in new page
In this webinar, Corey Waller, MD, MS; Holly Smith, MPH, MSN, CNM; Carrie Griffin, DO; Kathryn Ponder, MD; and Jadene Wong, MD discuss the Mother & Baby Substance Exposure Toolkit. This toolkit clarifies best practices to support and improve the care for substance exposed mothers and newborns.
ViewJune 30, 2020 - Webinar/Podcast/Video
open link in new page
In partnership with San Joaquin County, Health Management Associates presented an informative, engaging and practical presentation about treating pregnant women with Opioid Use Disorder (OUD)/Substance Use Disorder (SUD) during the COVID-19 Pandemic. We heard from Dr. Helen DuPlessis - Director of the Mother and Baby Substance Exposure Initiative (MBSEI), and Shelly Virva - MBSEI Subject Matter Expert.
May 14, 2020 - Webinar/Podcast/Video
open link in new page
In partnership with Sacramento County, Health Management Associates presented an informative, engaging and practical presentation about treating pregnant women with Opioid Use Disorder (OUD)/Substance Use Disorder (SUD) during the COVID-19 pandemic. We heard from Dr. Helen DuPlessis - Director of the Mother and Baby Substance Exposure Initiative, and Shelly Virva - MBSEI Subject Matter Expert.
July 7, 2020 - Webinar/Podcast/Video
open link in new page
In partnership with Fresno County, Health Management Associates presented an informative, engaging and practical presentation about treating pregnant women with Opioid Use Disorder (OUD)/Substance Use Disorder (SUD) during the COVID-19 Pandemic. We heard from Dr. Helen DuPlessis - Director of the Mother and Baby Substance Exposure Initiative (MBSEI), and Shelly Virva - MBSEI Subject Matter Expert.
July 29, 2020 - Webinar/Podcast/Video
open link in new page
In this webinar we discuss how pregnant women and their newborns are affected by the rising incidence of fentanyl and fentanyl analogues in the drug supply. Special focus will be placed on the pharmacokinetics and pharmacodynamic changes occurirng during pregnancy and the post-partum period.
November 18, 2020 - Webinar/Podcast/Video
open link in new page
In partnership with the OC Juvenile Courts, Health Management Associates invites you to register and join us for a webinar called: The Courts and Perinatal Substance Use: Evidence and Conundrums in Diagnosis, Treatment and Consequences. Health Management Associates (HMA) is providing training and technical assistance in 12 California counties to address substance and opioid use disorder in the perinatal population. This interactive workshop – provided by the leadership of the Mom and Baby Substance Exposure Initiative, a state opioid response grantee – will include a discussion of current evidence, best practices and information about perinatal substance use.
August 5, 2020 & August 12, 2020 - Webinar/Podcast/Video
open link in new page
In partnership with San Joaquin County Behavioral Services, Health Management Associates presented an informative, engaging and practical webinar about supporting pregnant women with behavioral health conditions and motivating women to conquer their tobacco use, all while working on caregiver resilience. Participants learned how to best support mothers and had their questions answered by Dr. Lori Raney and Bren Manaugh. The webinar was hosted on August 5th and 12th.
Viewing 12 of 124 resources